DeFi Technologies Inc. (the “Company” or “DeFi Technologies”) (Nasdaq: DEFT) (CBOE CA: DEFI) (GR: R9B), a financial technology company bridging the gap between traditional capital markets and decentralized finance (“DeFi”), today issued a Year-End Letter to Shareholders from its Chief Executive Officer and Executive Chairman, Johan Wattenström. https://mma.prnewswire.com/media/2852666/DeFi_Technologies_Inc__DeFi_Technologies_Issues_Year_End_CEO_Let.jpg Dear Shareholders, As we close 2025, I […]

C$ unless otherwise stated Manulife Investments today announced the final December 2025 cash distributions forManulife Exchange Traded Funds (ETFs) and ETF series of Manulife Mutual Funds, including Manulife Alternative Mutual Funds (Manulife Funds). Unitholders of record at the close of business on December 30, 2025, will receive cash distributions payable on January15, 2026. Details of

C$ unless otherwise stated Manulife Investments today announced the final 2025 annual reinvested distributions for Manulife Exchange Traded Funds (ETFs) and for ETF series of Manulife Mutual Funds, including Manulife Alternative Mutual Funds (Manulife Funds). These annual reinvested distributions generally represent realized capital gains within the ETFs or ETF series of a Manulife Fund. Unitholders

InflaRx Provides Update on Phase 3 Data Analyses for Vilobelimab in Pyoderma Gangrenosum GlobeNewswire December 30, 2025 While the Phase 3 trial of vilobelimab in ulcerative pyoderma gangrenosum (PG) was terminated earlier this year due to futility regarding its prespecified primary endpoint (as previously disclosed), subsequent post-hoc analyses suggest a positive trend in favor of

XOMA Royalty and Takeda Execute Strategic Royalty Sharing Transaction and Amend Existing Agreement for Mezagitamab GlobeNewswire December 30, 2025 – Takeda regains a majority of XOMA Royalty's royalty interest in mezagitamab (TAK-079) –– XOMA Royalty will be entitled to payments based on a share of milestones and royalties associated with nine development-stage assets held within

AMAYA BIG SKY CAPITAL ANNOUNCES TSXV CONDITIONAL ACCEPTANCE AND FILING OF FILING STATEMENT FOR QUALIFYING TRANSACTION GlobeNewswire December 30, 2025 Vancouver, B.C., Dec. 30, 2025 (GLOBE NEWSWIRE) — Amaya Big Sky Capital Corp. (“Amaya” or the “Company“) (TSX-V: AMYA.P), a capital pool company pursuant to Policy 2.4 of the TSX Venture Exchange (the “TSX-V“), is

Profusa Restructures Senior Secured Convertible Notes, Only Convertible Above $0.35 GlobeNewswire December 30, 2025 New note provides greater repayment flexibility and less dilution with elimination of mandatory amortization payments, increased conversion floor price to $0.35, and expanded mandatory ELOC payments from 33% to 50% BERKELEY, Calif, Dec. 30, 2025 (GLOBE NEWSWIRE) — Profusa, Inc. (“Profusa”

Purpose Investments Inc. Announces Final December 2025 Distribution Rate for Purpose High Interest Savings Fund, Purpose US Cash Fund, Purpose Cash Management Fund, and Purpose USD Cash Management Fund GlobeNewswire December 30, 2025 TORONTO, Dec. 30, 2025 (GLOBE NEWSWIRE) — Purpose Investments Inc. announced today the final December 2025 distribution rates for Purpose High Interest

AGF Investments Announces Final Distributions for AGF Investments ETFs for 2025 GlobeNewswire December 30, 2025 TORONTO, Dec. 30, 2025 (GLOBE NEWSWIRE) — AGF Investments Inc. (AGF Investments) today announced the final December 2025 cash distributions and annual 2025 reinvested capital gains distributions for the AGF Investments ETFs listed on the Toronto Stock Exchange or Cboe

Beyond Air(R) Appoints Dan Moorhead as Chief Financial Officer GlobeNewswire December 30, 2025 GARDEN CITY, N.Y., Dec. 30, 2025 (GLOBE NEWSWIRE) — Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve the lives of patients,